2008
DOI: 10.1529/biophysj.107.121384
|View full text |Cite
|
Sign up to set email alerts
|

Intermolecular Association Provides Specific Optical and NMR Signatures for Serotonin at Intravesicular Concentrations

Abstract: Neurotransmitter vesicles contain biomolecules at extraordinarily high concentrations (hundreds of millimoles/liter). Such concentrations can drive intermolecular associations, which may affect vesicular osmolarity and neuronal signaling. Here we investigate whether aqueous serotonin (a monoamine neurotransmitter) forms oligomers at intravesicular concentrations and whether these oligomers have specific spectroscopic signatures that can potentially be used for monitoring neuronal storage and release. We report… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0

Year Published

2008
2008
2023
2023

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 17 publications
(16 citation statements)
references
References 38 publications
0
16
0
Order By: Relevance
“…Rh‐123 accumulates specifically in the mitochondria of living cells (Johnson et al, 1980; Darzynkiewicz et al, 1981). This dye emits at a wavelength at about 550 nm and can be separated from serotonin, which emits at a shorter wavelength (Nag et al, 2008). We labeled the cells with rh‐123 and recorded images with a multiphoton microscope setup with two detection channels (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Rh‐123 accumulates specifically in the mitochondria of living cells (Johnson et al, 1980; Darzynkiewicz et al, 1981). This dye emits at a wavelength at about 550 nm and can be separated from serotonin, which emits at a shorter wavelength (Nag et al, 2008). We labeled the cells with rh‐123 and recorded images with a multiphoton microscope setup with two detection channels (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…1,2 It is involved in the regulation of mood, stress, sleep, pain, aggression, anger, learning and regulation of body temperature and blood pressure. 1,[5][6][7][8][9][10] Moreover, serotonin is the target, at least partially, for most drugs that are currently used for the treatment of psychiatric disorders (e.g., depression and schizophrenia). 1,[5][6][7][8][9][10] Moreover, serotonin is the target, at least partially, for most drugs that are currently used for the treatment of psychiatric disorders (e.g., depression and schizophrenia).…”
Section: Introductionmentioning
confidence: 99%
“…1,[5][6][7][8][9][10] Moreover, serotonin is the target, at least partially, for most drugs that are currently used for the treatment of psychiatric disorders (e.g., depression and schizophrenia). 2,6,11,12 It is generally accepted that some particular conformation of a biologically active molecule at the receptor site is decisive in order to trigger a specic biological response. The biological signicance of this molecule has drawn considerable theoretical and experimental interest for exploring its structure in the gas phase.…”
Section: Introductionmentioning
confidence: 99%
“…Serotonin is an aromatic compound with a nitrogen-containing cycle (indole) bearing an OH group and an ethylamine chain ( Fig. 23 Like glutamate, serotonin can interact with either ionotropic or metabotropic receptors. At physiological pH, the amine group is positively charged.…”
Section: Neurotransmitters and Their Receptors: What Physicochemical mentioning
confidence: 99%
“…The same sialic acid has the methyl of its N-acetyl group oriented toward the aromatic ring of serotonin, consistent with the establishment of a CH-π interaction. In the specific case of serotonin, which displays self-aggregating properties in water, 23 this process would also be a simple way to prevent aggregation, ensuring the efficient delivery of serotonin monomers to its postsynaptic receptors. 33 It has been hypothesized that the transient binding of serotonin to the gangliosides of the postsynaptic membrane take place immediately after the release of the neurotransmitter in the synaptic cleft.…”
Section: A Dual Receptor Model For Serotoninmentioning
confidence: 99%